| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.2B | $1.1B | $1.0B | $1.0B | $1.0B | $0.9B | $0.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.7B | $0.7B | $0.7B | $0.8B | $0.7B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $6.97 | $6.92 | $6.56 | $7.75 | $6.13 | $1.10 | $1.50 | $1.32 |
| EPS (Diluted) | $6.90 | $6.85 | $6.50 | $7.72 | $6.11 | $1.10 | $1.49 | $1.31 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.4B | $7.1B | $6.4B | $5.7B | $5.7B | $5.2B | $3.9B | $3.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $1.7B | $1.5B | $1.3B | $1.3B | $1.5B | $1.3B | $0.9B | $0.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $5.8B | $5.6B | $5.1B | $4.5B | $4.2B | $3.9B | $3.0B | $2.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.9B | $0.8B | $0.6B | $0.7B | $0.7B | $0.6B | $0.6B |
| Investing Cash Flow | $-0.2B | $-0.7B | $-0.5B | $-0.4B | $-0.6B | $-1.2B | $-0.5B | $-0.5B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.7B | $-0.2B | $-0.2B | $-0.2B | $-0.1B | $0.5B | $-0.0B | $-0.1B |